Display options
Share it on

Surg Case Rep. 2016 Dec;2(1):50. doi: 10.1186/s40792-016-0178-x. Epub 2016 May 26.

Pathological complete response after percutaneous isolated hepatic perfusion in hepatocellular carcinoma with portal vein tumor thrombosis: a case report.

Surgical case reports

Keisuke Arai, Takumi Fukumoto, Motofumi Tanaka, Kaori Kuramitsu, Masahiro Kido, Hisoka Kinoshita, Taku Matsumoto, Hirochika Toyama, Sadaki Asari, Tadahiro Goto, Tetsuo Ajiki, Yonson Ku

Affiliations

  1. Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Graduate School of Medicine,, Kobe University, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan. [email protected].
  2. Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Graduate School of Medicine,, Kobe University, 7-5-2, Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017, Japan.

PMID: 27230652 PMCID: PMC4881067 DOI: 10.1186/s40792-016-0178-x

Abstract

BACKGROUND: Although the effectiveness of perioperative adjuvant therapy in the treatment of hepatocellular carcinoma (HCC) has been investigated, the efficacy of preoperative therapy is unclear. Herein, we report a case of pathological complete response after percutaneous isolated hepatic perfusion (PIHP) for HCC involving portal vein tumor thrombosis (PVTT).

CASE PRESENTATION: A 77-year-old woman was referred to our institute with a liver mass detected on a routine health screening. Computed tomography revealed a 28 × 25 mm HCC in the left lobe of the liver and a tumor thrombus in the left and right portal branches (T4N0M0, stage IVA). The patient received a single dose of preoperative PIHP with doxorubicin plus mitomycin C, without severe toxicity. After the chemotherapy, she underwent extended left hepatic lobectomy and thrombectomy of the PVTT. No cancer cells were detected during histopathological analysis, indicating pathological complete response. She remained relapse-free 12 months after the surgery.

CONCLUSIONS: We experienced a case of pathological complete response after preoperative PIHP with doxorubicin plus mitomycin C for HCC involving PVTT.

Keywords: Hepatocellular carcinoma; Percutaneous isolated hepatic perfusion; Portal vein tumor thrombosis; Preoperative chemotherapy

References

  1. Semin Liver Dis. 2010 Feb;30(1):61-74 - PubMed
  2. Lancet. 2012 Mar 31;379(9822):1245-55 - PubMed
  3. Hepatology. 1999 Jan;29(1):62-7 - PubMed
  4. Hepatology. 2000 Aug;32(2):233-8 - PubMed
  5. J Am Coll Surg. 2006 Mar;202(3):431-8 - PubMed
  6. Arch Surg. 2000 Nov;135(11):1273-9 - PubMed
  7. Hepatol Res. 2015 Jan;45(2):null - PubMed
  8. Int J Surg Case Rep. 2015;10:20-4 - PubMed
  9. J Am Coll Surg. 2000 Dec;191(6):657-60 - PubMed
  10. Gut Liver. 2010 Jun;4(2):266-9 - PubMed
  11. Ann Surg. 2004 Jan;239(1):53-60 - PubMed
  12. Kaohsiung J Med Sci. 2015 Feb;31(2):77-82 - PubMed
  13. World J Surg. 2006 Nov;30(11):2004-11; discussion 2012-3 - PubMed
  14. Ann Surg. 1998 Mar;227(3):433-9 - PubMed
  15. World J Hepatol. 2015 Feb 27;7(2):245-52 - PubMed
  16. Surgery. 1996 May;119(5):517-22 - PubMed
  17. Ann Surg. 1998 Apr;227(4):519-26 - PubMed
  18. J Gastrointest Surg. 2009 Nov;13(11):1921-8 - PubMed
  19. Clin J Gastroenterol. 2011 Feb;4(1):43-8 - PubMed
  20. Dig Dis. 2015 Oct;33(6):765-70 - PubMed
  21. Surgery. 2005 Apr;137(4):403-10 - PubMed
  22. Ann Surg Oncol. 2014 Mar;21(3):971-8 - PubMed
  23. World J Gastroenterol. 2015 Mar 28;21(12):3462-71 - PubMed
  24. Ann Surg Oncol. 2010 Aug;17(8):2073-80 - PubMed
  25. Ann Surg. 2001 Mar;233(3):379-84 - PubMed
  26. Liver Int. 2010 Feb;30(2):166-74 - PubMed
  27. Surg Today. 2000;30(1):82-5 - PubMed

Publication Types